-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Opiant Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2011 to 2021.
- Opiant Pharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2022 was -1.93 USD/shares, a 351% decline year-over-year.
- Opiant Pharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2022 was -6.49 USD/shares.
- Opiant Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2021 was 0.68 USD/shares.
- Opiant Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2020 was -0.44 USD/shares, a 115% decline from 2019.
- Opiant Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2019 was 2.88 USD/shares.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)